Advertisement

Brugada Syndrome

  • Scott MankowitzEmail author
Chapter

Abstract

Brugada syndrome is a rare autosomal dominant condition characterized by mutations in cardiac sodium channels, which cause specific ECG findings and increase the risk of ventricular fibrillation and sudden cardiac death. Untreated Brugada syndrome has mortality of about 10% per year. The sole effective treatment is placement of an implantable cardiac defibrillator.

Keywords

Arrhythmia Brugada syndrome Sudden cardiac death Pregnancy 

References

  1. 1.
    Yap Y, et al. Drug-induced Brugada syndrome. Europace. 2009;11:989–94.CrossRefGoogle Scholar
  2. 2.
    Di Diego J. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation. 2002;106(15):2004–11.CrossRefGoogle Scholar
  3. 3.
    Rodríguez-Mañero M, et al. The clinical significance of pregnancy in Brugada syndrome. Rev Esp Cardiol (Engl Ed). 2014;67(3):176–80.CrossRefGoogle Scholar
  4. 4.
    Sorajja D, et al. Brugada syndrome and its relevance in the perioperative period. Ann Card Anaesth. 2015;18:403–13.CrossRefGoogle Scholar
  5. 5.
    Mizusawa Y, Wilde A. Brugada Syndrome. Circ Arrhythm Electrophysiol. 2012;5:606–16.CrossRefGoogle Scholar
  6. 6.
    BrugadaDrugs.org. [Online]. [cited 2016 June 14. Available from: http://www.brugadadrugs.org/

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Emergency Medical AssociatesParsippanyUSA
  2. 2.Emergency Medicine SpecialistEast Orange General HospitalEast OrangeUSA

Personalised recommendations